“Even though hospital budgets have significantly increased year, the majority of spending is going towards COVID related items. This gives manufacturers an extra year to register and build a strategic  plan for 2021-2022 when hospitals will restart their upgrades and reinvestments.”

Ilham Hidayattulah

Principal Consultant, Indonesia

Come grow with us in the US in Thailand in China in Korea in the Philippines in Taiwan in Hong Kong

Sources and Links

Indonesia Market Summary and Registered Devices Review

Published on: October 23, 2020

Market Snapshot

In recent years, the government has made healthcare a priority for the 261 million Indonesians, providing a lot of potential for medical device manufacturers of all technology levels. The government has also taken numerous steps to curb corruption through their online e-catalogue and other methods which has helped bring in more foreign companies and investment. According to the International Trade Administration, Indonesia imported $1.55 billion worth of medical devices in 2019, with about 20% coming from China, 15% from Germany, and 11% from the US. There is an estimate 2,877 hospitals (1,047 public / 1,830 private) with many public hospitals being consolidated to help increase efficiency1.

Foreign manufacturers are able to own up to 49% of a local importer-distributor but will need to meet additional production requirements if they want to own 100%. This, combined with a history of corruption, means manufacturers should continue to work with an independent partner that can ensure local regulations are met while maintaining complete control over their product and its marketability. Medical equipment is also subject to an import tax that varies depending on the type, along with the standard 10% VAT1. Halal certification is also currently not required but will begin to be implemented in 2021.

Who’s Registering Products in Indonesia

The Indonesian Ministry of Health maintains an e-catalogue of products available for sale as part of their effort to maintain transparency and combat corruption. Asia Actual has been able to gain unique insight into the registered products to help medical device manufacturers better evaluate the market specific to their product type. Indonesia imports 90% of their medical devices, especially when it comes to high tech therapies and hold only 9.84% of product registrations2.

As in most countries, IVDs are highly saturated product categories but we’ve also found that equipment for surgery, general hospital use and radiology are competitive as well. Regarding manufacturers, we found that similar categories were also saturated as seen below.

Product Category Snapshot – Gastro-Urology
TypeProducts Countries of Origin
Prosthetics 41
Surgical 18917
Therapeutic 36930
Imported Product Categories by Country of Origin
Country of Origin Products Importers
China 3,280462
United States 2,575203
United Kingdom63979

Top 10 Categories by Products Registered

Product CategoryProducts Importers
Clinical Chemistry Test Systems 1,964140
Surgical Equipment1,730304
Equipment General Hospital and Personal Therapeutic1,069213
Diagnostic Radiology Equipment758136
Anesthesia Equipment Therapeutics 698168
General Hospital Equipment and Other Individuals 62464
Immunology Test Systems 62464
Reagent Serology60286
Prosthetic Orthopedic Equipment52460
Clinical Laboratory Equipment522108

Top 10 Categories by Importers

Product CategoryProductsImporters
Surgical Equipment1,730304
Equipment General Hospital and Personal Therapeutic1,069213
General Hospital Equipment and Other Individuals624197
Anesthesia Equipment Therapeutics698168
Clinical Chemistry Test Systems1,964140
Diagnostic Radiology Equipment758136
Obstetrics and Gynecology Equipment Surgery375114
Clinical Laboratory Equipment 522108
Gastroenterology-Urology Therapeutic Equipment
Diagnostic Cardiology Equipment 43195

If you would like to learn more about your product category, please reach out here for support and if you want to explore the e-catalogue yourself, please find directions here or along the sidebar.

COVID Update

As of October 21, the Health Ministry reported an additional 4,267 new cases, bringing the total number of infections to 373,109 with 12,857 deaths. Cases have plateaued in the last month after reaching a daily high of 4,823 new infections on September 253. Indonesia currently has 376 laboratories with a combined testing capacity of 40,000 specimens per day to serve the population of 260 million people. The government has also taken some significant steps, capping the cost of COVID tests, setting a goal of obtaining 670,000 vials of remdesivir by the end of 20204, and have set up the National Economic Recovery Task Force with a budget of IDR 695.2 trillion budget, the majority spent on social protection programs. Some businesses are able to open to 25% but high-risk locations like karaoke bars and night clubs remain closed with contact tracing being implemented among all open businesses5.

Indonesia and Singapore have also implemented a Reciprocal Green Lane (RGL) agreement that allows qualifying essential businesspeople to travel back and forth. Only citizens of Singapore and Indonesia are eligible to apply for this program5.

While the government’s hospital budget has doubled in 2020 from IDR 9 trillion (US$613.5 million) to IDR 18 Trillion (US$1.2 billion), most of the budget will be spent on PPE and other pandemic specific products. When combined with the APBD (Regional Revenue Expenditure Budget), and private budgets, the total expenditure on medical equipment in Indonesia averages around IDR 50 trillion (US$3.4 billion) per year. Even though upgrading hospitals and the healthcare infrastructure remain a top priority for the Indonesian government; upgrades, elective surgeries, and dentist offices will likely decline until COVID pandemic can be addressed. As a result, medical equipment transactions are only at about half of what they would be under normal conditions this year.

Who’s Registering Products During COVID

The Ministry of Health has provided priority pathways and accelerated One Day Service (ODS) services for licensing medical devices used for Covid-19 management. During the period January 1, 2020 – June 30, 2020, there was a significant increase in product approval for medical device and Household Health Supplies (PKRT) due to this relaxation, along with PPE. Apart from domestic products, the impact of this relaxation has also increased the number of imported products being approved. Many of the imported products include medical devices used to carry out diagnostic tests for Covid-19 patients such as PCR devices, reagents, and swab kits.

The below table is a snapshot of products that have been approved in the first half of this year compared to last year7.

Table 1. Personal Protective Equipment Approval
No Product Domestic products Imported products
Approval Applicant Approval Applicant
2019 2020 2019 2020 2019 2020 2019 2020
1 Surgical Masks 104 172 28 102 31 32 15 22
2 KN95 Masks 0 5 0 4 1 14 1 11
3 Coveralls 0 212 0 135 0 13 0 13
4 Surgical Gowns 1 29 1 23 13 4 2 4
5 Hair Nets 18 8 11 7 5 0 4 0
6 Examination Gloves 28 17 12 10 63 32 29 12
7 Surgical Gloves 7 9 3 6 23 30 15 15
8 Goggles 0 5 0 4 0 7 0 5
9 Shoe Covers 1 12 1 11 0 0 0 0
Table 2. Hand Sanitizer and Disinfectant Approval
No Product Domestic Products Imported Products
Approval Applicant Approval Applicant
2019 2020 2019 2020 2019 2020 2019 2020
1 Hand Sanitizers 38 1006 28 398 8 54 8 21
2 Disinfectants 52 337 31 176 14 16 7 9

If you would like to learn more about registered products in Indonesia, support evaluating your product’s potential in the market, or want to learn more about the registration process, please contact Asia Actual today for support.

Blog Posts

CDSCO Issues Updates to IVD Classification List in India

The Central Drugs Standard Control Organisation (CDSCO) of India issued a notice (PDF) on October 25, 2023 classifying in-vitro diagnostic (IVD) medical devices under medical device rules. The updates to IVD classification in India include intended use, associated risk, and other parameters.

Embracing Innovation and Collaboration: Highlights from the 15th CII Global MedTech Summit

On October 6, 2023, a team of enthusiastic members from the AAI (Artificial Intelligence and Innovation) group, including Ashoniya Puri, Sanjay Singh, and Rajat Budhori, had the honor of attending the prestigious 15th CII Global MedTech Summit. Hosted by the Confederation of Indian Industry (CII), one of India's largest industry bodies, this event brought together key players in the MedTech sector, both from India and abroad. The summit revolved around the central theme, "Paving the way for a USD 50 billion MedTech Industry by 2030," signifying a collective vision for the industry's future growth.


On September 18, 2023, The Directorate General of Drug Administration (DGDA) published the Drug and Cosmetics Act 2023 formalizing the regulatory requirements of medical and diagnostic devices in Bangladesh with immediate effect.  A translated version of the document is available on Asia Actual’s website here.  All medical devices now require a Marketing Authorization Certificate to clear Customs and be sold on the market in Bangladesh.